Lymphatic filariasis-associated lymphedema: pathogenesis, diagnosis, management, and global elimination
Clinical Microbiology Reviews · 16.11.2026
DOI: 10.1128/cmr.00044-26 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Microbiology Reviews, online erschienen am 16.11.2026. Verfasst von Saravu R Narahari und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Applied Dermatology, Kasaragod, Kerala, India. Die Arbeit nennt 289 Literaturangaben.
Abstract (Originalsprache)
Filarial lymphedema (FL), a chronic consequence of lymphatic filariasis, represents one of the most neglected manifestations of helminth infection, despite affecting an estimated 120 million individuals across tropical and subtropical regions. More than 40 million people live with irreversible limb or genital disfigurement, accompanied by lifelong pain, disability, psychological distress, and social stigma. Unlike other causes of lymphedema, FL arises from sustained host-parasite interactions, in which prolonged immune modulation, microbial persistence, and secondary infections drive progressive lymphatic damage. Disease transmission and early pathology often remain clinically silent for years, allowing lymphatic injury to accumulate before overt swelling becomes apparent. Although global elimination efforts have reduced transmission, individuals with established FL remain largely neglected, highlighting a critical disconnect between parasite control and morbidity management. Current interventions are limited to hygiene-based care, infection control, and conservative limb management; no vaccine or curative therapy exists for established lymphatic failure. Diagnostic approaches primarily capture infection status rather than ongoing immune-mediated tissue damage, constraining disease staging, monitoring, and therapeutic evaluation in resource-limited settings. This review synthesizes current knowledge on the immunopathogenesis of FL, emphasizing the roles of chronic inflammation, genetics, immune dysregulation, microbial translocation, and lymphatic adipose tissue remodeling in disease persistence. We highlight emerging diagnostic biomarkers, therapeutic targets, and integrative management strategies, and outline critical gaps that hinder effective morbidity reduction. Advancing stage-specific diagnostic approaches and exploring intervention mechanisms will be essential to improve quality of life for affected individuals and achieve meaningful, sustainable elimination of lymphatic filariasis-associated morbidity.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Applied Dermatology, Kasaragod, Kerala, India.
- Department of Biological Sciences, SRM University AP, School of Engineering and Sciences (SEAS), Amaravathi, Andhra Pradesh, India.
- Green Templeton College, University of Oxford, Oxford, United Kingdom.
- Institute for Bioanalytics, Faculty of Applied Natural Sciences and Health, Coburg University of Applied Sciences and Arts, Coburg, Germany.
- Proteomics Unit, Department of Preclinical Development and Validation, Fraunhofer Institute for Cell Therapy and Immunology (IZI), Leipzig, Germany.
- Molecular and Clinical Sciences Research Institute, St George's University of London, London, United Kingdom.
ORCID-Profile: Pavithra Rajkumar, Jayaseelan Murugaiyan
Zitieren
APA
Narahari, S. R., Rajkumar, P., Kumari, P., Ryan, T. J., Kalkhof, S., Mortimer, P. S., & Murugaiyan, J. (2026). Lymphatic filariasis-associated lymphedema: pathogenesis, diagnosis, management, and global elimination. Clinical Microbiology Reviews. https://doi.org/10.1128/cmr.00044-26
Vancouver
Narahari SR, Rajkumar P, Kumari P, Ryan TJ, Kalkhof S, Mortimer PS, et al. Lymphatic filariasis-associated lymphedema: pathogenesis, diagnosis, management, and global elimination. Clinical Microbiology Reviews. 2026. doi:10.1128/cmr.00044-26
BibTeX
@article{Narahari2026,
author = {Narahari, Saravu R and Rajkumar, Pavithra and Kumari, Pooja and Ryan, Terence J and Kalkhof, Stefan and Mortimer, Peter S and Murugaiyan, Jayaseelan},
title = {Lymphatic filariasis-associated lymphedema: pathogenesis, diagnosis, management, and global elimination},
journal = {Clinical Microbiology Reviews},
year = {2026},
doi = {10.1128/cmr.00044-26}
}
EUVIMED